Association of vitamin D receptor gene polymorphisms with type 2 diabetes mellitus in Taif population: a case-control study / Associação de polimorfismos do gene do receptor de vitamina D com diabetes mellitus tipo 2 na população Taif: um estudo de caso-controle

Abstract Several reasons may underlie the dramatic increase in type2 diabetes mellitus. One of these reasons is the genetic basis and variations. Vitamin D receptor polymorphisms are associated with different diseases such as rheumatoid arthritis and diabetes. The aim of this study is to investigate the possible association of two identified mutations ApaI (rs7975232) and TaqI (rs731236). Eighty-nine healthy individuals and Fifty-six Type 2 Diabetic (T2D) patients were investigated using RFLP technique for genotyping and haplotyping as well. The distribution of Apal genotypes was not statistically significant among the control (P=0.65) as well as for diabetic patients (P=0.58). For Taql allele frequencies of T allele was 0.61 where of G allele was 0.39. The frequency distribution of Taql genotypes was not statistically significant among the control (P=0.26) as well as diabetic patients (P=0.17). Relative risk of the allele T of Apa1 gene is 1.28 and the odds ratio of the same allele is 1.53, while both estimates were < 1.0 of the allele G. Similarly, with the Taq1 gene the relative risk and the odds ratio values for the allele T are 1.09 and 1.27 respectively and both estimates of the allele C were 0.86 for the relative risk and 0.79 for the odds ratio. The pairwise linkage disequilibrium between the two SNPs Taq1/apa1 was statistically significant in control group (D = 0.218, D' = 0.925 and P value < 0.001) and similar data in diabetic groups (D = 0.2, D' = 0.875 and P value < 0.001). These data suggest that the T allele of both genes Apa1 and Taq1 is associated with the increased risk of type 2 diabetes. We think that we need a larger number of volunteers to reach a more accurate conclusion.

Resumo Várias razões podem estar subjacentes ao aumento dramático da diabetes mellitus tipo 2. Um desses motivos é a base genética e variações. Os polimorfismos do receptor da vitamina D estão associados a diferentes doenças, como artrite reumatoide e diabetes. O objetivo deste estudo é investigar a possível associação de duas mutações identificadas ApaI (rs7975232) e TaqI (rs731236). Oitenta e nove indivíduos saudáveis ​​e 56 pacientes com diabetes tipo 2 (T2D) foram investigados usando a técnica RFLP para genotipagem e haplotipagem também. A distribuição dos genótipos Apal não foi estatisticamente significativa entre o controle (P = 0,65), bem como para os pacientes diabéticos (P = 0,58). Para as frequências do alelo Taql, o alelo T foi de 0,61, onde o alelo G foi de 0,39. A distribuição de frequência dos genótipos Taql não foi estatisticamente significativa entre o controle (P = 0,26), bem como os pacientes diabéticos (P = 0,17). O risco relativo do alelo T do gene Apa1 é 1,28 e a razão de chances do mesmo alelo é 1,53, enquanto ambas as estimativas foram < 1,0 do alelo G. Da mesma forma, com o gene Taq1, os valores de risco relativo e razão de chances para o alelo T são 1,09 e 1,27, respectivamente, e ambas as estimativas do alelo C foram de 0,86 para o risco relativo e 0,79 para o odds ratio. O desequilíbrio de ligação par a par entre os dois SNPs Taq1 / apa1 foi estatisticamente significativo no grupo de controle (D = 0,218, D' = 0,925 e valor P < 0,001) e dados semelhantes em grupos diabéticos (D = 0,2, D' = 0,875 e valor P < 0,001). Esses dados sugerem que o alelo T de ambos os genes Apa1 e Taq1 está associado ao aumento do risco de diabetes tipo 2. Achamos que precisamos de um número maior de voluntários para chegar a uma conclusão mais precisa.

Association of vitamin D receptor gene polymorphisms with type 2 diabetes mellitus in Taif population: a case-control study

Abstract Several reasons may underlie the dramatic increase in type2 diabetes mellitus. One of these reasons is the genetic basis and variations. Vitamin D receptor polymorphisms are associated with different diseases such as rheumatoid arthritis and diabetes. The aim of this study is to investigate the possible association of two identified mutations ApaI (rs7975232) and TaqI (rs731236). Eighty-nine healthy individuals and Fifty-six Type 2 Diabetic (T2D) patients were investigated using RFLP technique for genotyping and haplotyping as well. The distribution of Apal genotypes was not statistically significant among the control (P=0.65) as well as for diabetic patients (P=0.58). For Taql allele frequencies of T allele was 0.61 where of G allele was 0.39. The frequency distribution of Taql genotypes was not statistically significant among the control (P=0.26) as well as diabetic patients (P=0.17). Relative risk of the allele T of Apa1 gene is 1.28 and the odds ratio of the same allele is 1.53, while both estimates were 1.0 of the allele G. Similarly, with the Taq1 gene the relative risk and the odds ratio values for the allele T are 1.09 and 1.27 respectively and both estimates of the allele C were 0.86 for the relative risk and 0.79 for the odds ratio. The pairwise linkage disequilibrium between the two SNPs Taq1/apa1 was statistically significant in control group (D = 0.218, D' = 0.925 and P value 0.001) and similar data in diabetic groups (D = 0.2, D' = 0.875 and P value 0.001). These data suggest that the T allele of both genes Apa1 and Taq1 is associated with the increased risk of type 2 diabetes. We think that we need a larger number of volunteers to reach a more accurate conclusion.

Resumo Várias razões podem estar subjacentes ao aumento dramático da diabetes mellitus tipo 2. Um desses motivos é a base genética e variações. Os polimorfismos do receptor da vitamina D estão associados a diferentes doenças, como artrite reumatoide e diabetes. O objetivo deste estudo é investigar a possível associação de duas mutações identificadas ApaI (rs7975232) e TaqI (rs731236). Oitenta e nove indivíduos saudáveis e 56 pacientes com diabetes tipo 2 (T2D) foram investigados usando a técnica RFLP para genotipagem e haplotipagem também. A distribuição dos genótipos Apal não foi estatisticamente significativa entre o controle (P = 0,65), bem como para os pacientes diabéticos (P = 0,58). Para as frequências do alelo Taql, o alelo T foi de 0,61, onde o alelo G foi de 0,39. A distribuição de frequência dos genótipos Taql não foi estatisticamente significativa entre o controle (P = 0,26), bem como os pacientes diabéticos (P = 0,17). O risco relativo do alelo T do gene Apa1 é 1,28 e a razão de chances do mesmo alelo é 1,53, enquanto ambas as estimativas foram 1,0 do alelo G. Da mesma forma, com o gene Taq1, os valores de risco relativo e razão de chances para o alelo T são 1,09 e 1,27, respectivamente, e ambas as estimativas do alelo C foram de 0,86 para o risco relativo e 0,79 para o odds ratio. O desequilíbrio de ligação par a par entre os dois SNPs Taq1 / apa1 foi estatisticamente significativo no grupo de controle (D = 0,218, D' = 0,925 e valor P 0,001) e dados semelhantes em grupos diabéticos (D = 0,2, D' = 0,875 e valor P 0,001). Esses dados sugerem que o alelo T de ambos os genes Apa1 e Taq1 está associado ao aumento do risco de diabetes tipo 2. Achamos que precisamos de um número maior de voluntários para chegar a uma conclusão mais precisa.

Trans-palmitoleic acid does not modify the inflammasome expression in a rodent model of diet-induced obesity / El ácido trans-palmitoléico no modifica la expresión del inflamasoma en un modelo murino de obesidad inducida por dieta

Abstract Background: Metabolic disorders such as obesity and type 2 diabetes (T2D) coincide with an increased expression of pro-inflammatory factors. The NLRP3 inflammasome is a complex that activates the pro-inflammatory cytokine IL-1β. (NOD-like receptor protein 3). Some nutrients, such as fatty acids, influence inflammatory processes. For example, in clinical studies, higher trans-palmitoyl acid (TP) concentrations coincide with lower adiposity and lower risk of developing T2D. This study aims to evaluate the effect of TP on NLRP3 expression in a rodent model of diet-induced obesity (DIO). Methods: C57BL/6J mice were fed ad libitum with a control or a high-fat diet (HFD), added with or without TP (3 g/kg diet), for 11 weeks. IL-1β was quantified in serum, and NLRP3-related gene expression was explored in epididymal adipose tissue. Results: Despite increased weight gain in both high-fat groups, the high-fat TP group gained less weight than the high-fat group. In addition, NLRP3 and caspase-1 expression was higher in the HFD groups, but no differences were observed between the HFD and the HFD TP groups. Serum IL-1β levels were not different among groups. Conclusions: Diet supplementation with TP prevents weight gain and has a neutral influence over NLRP3 expression and IL-1β concentration in a DIO mice model.

Resumen Introducción: Las alteraciones metabólicas como la obesidad y diabetes tipo 2 (DT2) coinciden con la expresión aumentada de factores proinflamatorios. Un complejo que induce la activación de la citocina proinflamatoria IL-1β es el inflamasoma NLRP3 (NOD-like receptor protein 3). Algunos nutrimentos, como los ácidos grasos, influencian los procesos inflamatorios. Por ejemplo, en estudios clínicos, mayores concentraciones del ácido trans-palmitoléico (TP) coinciden con una menor adiposidad y un menor riesgo de desarrollar DT2. El objetivo de este estudio fue evaluar el efecto del TP sobre la expresión del inflamasoma NLRP3 en un modelo de obesidad inducida por dieta (OID) en roedores. Métodos: Se alimentaron ratones C57BL/6J ad libitum con una dieta control o alta en lípidos (AL), adicionada o no con TP (3 g/kg dieta), durante 11 semanas. Se cuantificó la concentración de IL-1β en elsuero de los animales, y en el tejido adiposo epididimal se midió la expresión de los componentes del inflamasoma. Resultados: A pesar del aumento de peso en ambos grupos de dieta con alto contenido en lípidos, el grupo alto en lípidos TP ganó menos peso que el grupo AL. Por otro lado, la expresión de genes del inflamasoma resultó mayor en los grupos AL, pero no se encontraron diferencias entre los grupos AL y AL TP. Además, no se observaron diferencias en la concentración de IL-1β en suero entre grupos. Conclusiones: La dieta suplementada con TP previno el aumento del peso corporal, pero no modificó la expresión de los componentes del inflamasoma ni la concentración de IL-1β en suero.

Evaluación de la efectividad de la vitamina E en la esteatosis hepática no alcohólica en pacientes diabéticos tipo 2 sin fibrosis avanzada

Objetivo: Determinar la efectividad de la vitamina E en la esteatosis hepática no alcohólica (EHGNA) en pacientes diabéticos tipo 2 sin fibrosis avanzada. Materiales y métodos: Estudio analítico de tipo cuasi experimental. Se formaron dos grupos, un grupo experimental que recibió vitamina E de 400 UI además del manejo convencional, y otro grupo de control con manejo convencional. El estudio incluyó a 71 pacientes en cada grupo. Ambos grupos fueron sometidos al cálculo de un puntaje de fibrosis hepática, ecografía hepática y a la medición de la transaminasa glutámico-pirúvica al inicio del estudio y tras 6 meses. Asimismo, para comparar concentraciones de los valores de puntaje de fibrosis y de la transaminasa glutámico-pirúvica dentro de un mismo grupo se empleó la prueba Wilcoxon, y para evaluar diferencias entre el grupo experimental y control se realizó la prueba de U de Mann-Whitney. Para comparar la severidad ecográfica se empleó la prueba de Wilcoxon. Luego se realizó la regresión logística. Se procedió a registrar la información en una ficha de recolección de datos haciendo uso del programa Microsoft Excel, posteriormente, se procedió a codificar y generar una base de datos con el paquete estadístico SPSS v. 23. Resultados: Dentro de los resultados se halló que la vitamina E fue efectiva en reducir el puntaje fibrosis hepática, transaminasas y severidad ecográfica en forma significativa (Z = -4,727 y p < 0,05). De acuerdo al análisis de regresión lineal el nivel de TGP y de score de fibrosis no son explicados significativamente por las variables confusoras incluidas en el modelo al 95 % de confianza. Conclusiones: La vitamina E a una dosis de 400 UI vía oral durante 6 meses es una intervención efectiva para controlar la progresión de la hepatopatía que puede cuantificarse mediante puntaje de fibrosis, disminución de transaminasas y valoración ecográfica tras 6 meses de seguimiento.

Objective: To determine the effectiveness of vitamin E in nonalcoholic fatty liver disease (NAFLD) among type 2 diabetes patients without advanced fibrosis. Materials and methods: A quasi-experimental analytical study consisting of two groups: an experimental one, which received vitamin E 400 IU in addition to the standard treatment, and a control group, which received only the standard treatment. The study included 71 patients in each group. Both groups underwent liver fibrosis scoring, liver ultrasound and glutamate pyruvate transaminase measurement at study baseline and after six months. Moreover, the Wilcoxon test was used to compare the concentrations of fibrosis score and glutamate pyruvate transaminase values within the same group, and the Mann-Whitney U test was used to evaluate the differences between the experimental and control groups. The Wilcoxon test was also used to compare ultrasound severity. Then, a logistic regression analysis was performed. The information was entered into a data collection sheet using Microsoft Excel; afterwards, a database was coded and created using IBM SPSS Statistics statistical software 23.0. Results: Among the results, it was found that vitamin E was significantly effective in reducing liver fibrosis, transaminase and ultrasound severity scores (Z = -4.727 and p < 0.05). According to the logistic regression analysis, glutamate pyruvate transaminase levels and fibrosis score are not substantially explained by the confounding variables included in the model at 95 % confidence. Conclusions: Vitamin E at a dose of 400 IU given orally for six months is an effective intervention to control the progression of liver disease, which can be quantified by fibrosis score, transaminase reduction and ultrasound assessment after a 6-month follow-up.

Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans / Disbiose intestinal, inflamação e diabetes tipo 2 em camundongos usando microbiota intestinal sintética de humanos diabéticos

Abstract The study was aimed to assess impact of high fat diet (HFD) and synthetic human gut microbiota (GM) combined with HFD and chow diet (CD) in inducing type-2 diabetes (T2D) using mice model. To our knowledge, this is the first study using selected human GM transplantation via culture based method coupled dietary modulation in mice for in vivo establishment of inflammation leading to T2D and gut dysbiosis. Twenty bacteria (T2D1-T2D20) from stool samples of confirmed T2D subjects were found to be morphologically different and subjected to purification on different media both aerobically and anerobically, which revealed seven bacteria more common among 20 isolates on the basis of biochemical characterization. On the basis of 16S rRNA gene sequencing, these seven isolates were identified as Bacteroides stercoris (MT152636), Lactobacillus acidophilus (MT152637), Lactobacillus salivarius (MT152638), Ruminococcus bromii (MT152639), Klebsiella aerogenes (MT152640), Bacteroides fragilis (MT152909), Clostridium botulinum (MT152910). The seven isolates were subsequently used as synthetic gut microbiome (GM) for their role in inducing T2D in mice. Inbred strains of albino mice were divided into four groups and were fed with CD, HFD, GM+HFD and GM+CD. Mice receiving HFD and GM+modified diet (CD/HFD) showed highly significant (P<0.05) increase in weight and blood glucose concentration as well as elevated level of inflammatory cytokines (TNF-α, IL-6, and MCP-1) compared to mice receiving CD only. The 16S rRNA gene sequencing of 11 fecal bacteria obtained from three randomly selected animals from each group revealed gut dysbiosis in animals receiving GM. Bacterial strains including Bacteroides gallinarum (MT152630), Ruminococcus bromii (MT152631), Lactobacillus acidophilus (MT152632), Parabacteroides gordonii (MT152633), Prevotella copri (MT152634) and Lactobacillus gasseri (MT152635) were isolated from mice treated with GM+modified diet (HFD/CD) compared to strains Akkermansia muciniphila (MT152625), Bacteriodes sp. (MT152626), Bacteroides faecis (MT152627), Bacteroides vulgatus (MT152628), Lactobacillus plantarum (MT152629) which were isolated from mice receiving CD/HFD. In conclusion, these findings suggest that constitution of GM and diet plays significant role in inflammation leading to onset or/and possibly progression of T2D. .

Resumo O estudo teve como objetivo avaliar o impacto da dieta rica em gordura (HFD) e da microbiota intestinal humana sintética (GM) combinada com HFD e dieta alimentar (CD) na indução de diabetes tipo 2 (T2D) usando modelo de camundongos. Para nosso conhecimento, este é o primeiro estudo usando transplante de GM humano selecionado através do método baseado em cultura acoplada à modulação dietética em camundongos para o estabelecimento in vivo de inflamação que leva a T2D e disbiose intestinal. Vinte bactérias (T2D1-T2D20) de amostras de fezes de indivíduos T2D confirmados verificaram ser morfologicamente diferentes e foram submetidas à purificação em meios diferentes aerobicamente e anaerobicamente, o que revelou sete bactérias mais comuns entre 20 isolados com base na caracterização bioquímica. Com base no sequenciamento do gene 16S rRNA, esses sete isolados foram identificados como Bacteroides stercoris (MT152636), Lactobacillus acidophilus (MT152637), Lactobacillus salivarius (MT152638), Ruminococcus bromii (MT152639), Klebsiella aerogenides (MT152640), Bacteroides fragilis (MT152909), Clostridium botulinum (MT152910). Esses sete isolados foram, posteriormente, usados ​​como microbioma intestinal sintético (GM) por seu papel na indução de T2D em camundongos. Linhagens consanguíneas de camundongos albinos foram divididas em quatro grupos e foram alimentadas com CD, HFD, GM + HFD e GM + CD. Camundongos que receberam a dieta modificada com HFD e GM + (CD / HFD) mostraram um aumento altamente significativo (P < 0,05) no peso e na concentração de glicose no sangue, bem como um nível elevado de citocinas inflamatórias (TNF-α, IL-6 e MCP-1) em comparação com os ratos que receberam apenas CD. O sequenciamento do gene 16S rRNA de 11 bactérias fecais obtidas de três animais selecionados aleatoriamente de cada grupo revelou disbiose intestinal em animais que receberam GM. Cepas bacterianas, incluindo Bacteroides gallinarum (MT152630), Ruminococcus bromii (MT152631), Lactobacillus acidophilus (MT152632), Parabacteroides gordonii (MT152633), Prevotella copri (MT152634) e Lactobacillus Gasseri (MT152635D), foram tratadas com dieta modificada / CD) em comparação com as linhagens Akkermansia muciniphila (MT152625), Bacteriodes sp. (MT152626), Bacteroides faecis (MT152627), Bacteroides vulgatus (MT152628), Lactobacillus plantarum (MT152629), que foram isoladas de camundongos recebendo CD / HFD. Em conclusão, esses resultados sugerem que a constituição de GM e dieta desempenham papel significativo na inflamação levando ao início ou/e possivelmente à progressão de T2D.

Nefropatía diabética, condiciones de salud y estilos de vida en pacientes con diabetes tipo 2

Introducción: La nefropatía diabética es considerada un problema de salud pública de alta prevalencia, el cual tiene como principal factor de riesgo al estilo de vida no saludable que tiende a deteriorar la calidad de vida del individuo. Objetivo: "Relacionar el grado de nefropatía diabética, las condiciones de salud y los estilos de vida en pacientes con diabetes mellitus tipo 2 (DM2) del Hospital Hermilio Valdizán Medrano de Huánuco (Perú), durante el 2019". Métodos: Fue un estudio cuantitativo, de tipo observacional, transversal y ambiretrospectivo. La muestra fueron 112 pacientes con diagnóstico de DM2. Se revisaron las historias clínicas de los pacientes para evaluar el grado de nefropatía diabética, las condiciones de salud y también se les aplicó un cuestionario sobre estilos de vida. Para la contrastación de la hipótesis se utilizó la prueba Tau-c de Kendall. Resultados: Un 35,7 % tuvo nefropatía diabética grado 1 levemente aumentada; el 47, 3 % (53) tuvo una regular condición de salud. Con respecto al estilo de vida, un 69,6 % (78) tuvo un estilo de vida poco saludable. También se halló relación positiva y directa (Tc = 0,789; p = 0,000) entre las buenas condiciones de salud y la nefropatía diabética de grado 1 levemente aumentada. Conclusión: El grado de nefropatía diabética tiene relación significativa con las condiciones de salud y los estilos de vida saludables.

Introduction: Diabetic nephropathy is considered a highly prevalent public health problem, whose main risk factor is the unhealthy lifestyle that tends to deteriorate the quality of life of the individual. Objective: To relate the degree of diabetic nephropathy, health conditions and lifestyles in patients with type 2 diabetes mellitus (T2DM) at the Hermilio Valdizán Medrano Hospital in Huánuco (Peru), during 2019. Methods: It was a study with quantitative approach, observational, cross-sectional and ambiretrospective type. The sample consisted of 112 patients with a diagnosis of type 2 diabetes mellitus. The patients' medical records were reviewed to assess the degree of diabetic nephropathy, health conditions and a questionnaire on lifestyles was also applied. Kendall's Tau-c test was used to test the hypothesis. Results: It was found that a large proportion of the study sample (35.7%) had slightly increased grade 1 diabetic nephropathy; 47.3% (53) had a regular health condition. With respect to lifestyle, 69.6 % (78) had an unhealthy lifestyle. A positive and direct relationship (Tc = 0.789; p = 0.000) was also found between good health conditions and mildly increased grade 1 diabetic nephropathy. Conclusion: The degree of diabetic nephropathy has significant relationship with health conditions and healthy lifestyles.

Mortalidade de idosos por diabetes mellitus no Brasil: 1996 a 2021 / Mortality of elderly due to diabetes mellitus in Brazil: 1996 to 2021 / Mortalidad de ancianos por diabetes mellitus en Brasil: 1996 a 2021

Objetivo: Analisar a frequência de registros de óbito de idosos por diabetes mellitus (DM) no Brasil, nos anos de 1996 a 2021. Método: Estudo exploratório, comparativo, descritivo e de abordagem quantitativa. Os dados foram extraídos no Serviço de Informação sobre Mortalidade do Ministério da Saúde (SIM/MS). Resultados: Foi identificado o universo de "1.020.672" registros de óbitos por DM, com média e desvio padrão (39.256,6±12.953). As maiores preponderâncias foram de 41,9% (n=427.586) da região Sudeste (SE), 19,4% (n=197.995) do estado de São Paulo (SP), 85,1% (n=868.576) dos óbitos foram por DM não especificada (CID10: E14), 36,2% (n=369.855) possuíam de 70 a 79 anos, 51,3% (n=523.101) eram de cor/raça "branca", 23,2% (n=237.279) não possuíam "nenhuma" escolarização, 37,9% (n=387.194) eram casadas(os), 68,2% (n=696.158) tiveram registro de óbito no hospital. Conclusão: Foi verificado aumento na frequência de registros de óbito de idosos por DM no recorte geográfico e histórico analisados.

Objective: Analyzing the frequency of death records of elderly individuals due to diabetes mellitus (DM) in Brazil, from 1996 to 2021. Method: Exploratory, comparative, descriptive, and quantitative study. Data were extracted from the Mortality Information System of the Ministry of Health (SIM/MS). Results: A universe of "1,020,672" death records due to DM was identified, with a mean and standard deviation of (39,256.6±12,953). The highest prevalences were 41.9% (n=427,586) in the Southeast region (SE), 19.4% (n=197,995) in the state of São Paulo (SP), 85.1% (n=868,576) of deaths were due to unspecified DM (ICD-10: E14), 36.2% (n=369,855) were aged 70 to 79, 51.3% (n=523,101) were of "white" race/color, 23.2% (n=237,279) had "no" education, 37.9% (n=387,194) were married, and 68.2% (n=696,158) had a hospital death record. Conclusion: An increase in the frequency of death records of elderly individuals due to DM was observed in the analyzed geographical and historical context

Objetivo: Analizar la frecuencia de los registros de muerte de ancianos por diabetes mellitus (DM) en Brasil, de 1996 a 2021. Método: Estudio exploratorio, comparativo, descriptivo con abordaje cuantitativo. Los datos fueron extraídos del Servicio de Información de Mortalidad del Ministerio de Salud (SIM/MS). Resultados: Se identificó un universo de "1.020.672" actas de defunción por DM, con media y desviación estándar (39.256,6±12.953). Las mayores prevalencias fueron 41,9% (n= 427.586) en la región Sudeste (SE), 19,4% (n=197.995) en el estado de São Paulo (SP), 85,1% (n=868.576) de las muertes fueron por DM no especificada (CID-10: E14), 36,2% (n=369.855) tenían entre 70 y 79 años, 51,3% (n= 523.101) eran de color/raza "blanca", 23,2% (n=237.279) tenían "ninguna" escolaridad, El 37,9 % (n=387.194) estaban casados, el 68,2% (n=696.158) tenían registro de defunción en el hospital. Conclusión: Hubo un aumento en la frecuencia de registros de muerte de ancianos por DM en el área geográfica e histórica analizada

Programa Dia-D: ensaio propositivo de intervenção educativa para autogerenciamento em diabetes tipo 2 / Programa Dia-D: ensayo propositivo de una intervención educativa para el autocuidado en diabetes tipo 2 / Dia-D Program: propositional essay of an educational intervention for self-management in type 2 diabetes

Resumo Objetivo apresentar o Programa Diabetes em Dia (Dia-D): uma intervenção educativa para autogerenciamento do diabetes tipo 2 focada em promover alimentação saudável, prática regular de atividade física e uso correto de medicamentos entre adultos com diabetes tipo 2. Método ensaio propositivo de intervenção complexa, fundamentado em dois modelos comportamentais: The ADCES7 Self-Care Behaviors™ (Associação de Especialistas em Cuidados e Educação em Diabetes); e Behaviour Change Wheel (BCW). Resultados a estrutura conceitual "Capability, Opportunity, Motivation-Behaviour (COM-B)" do BCW possibilitou a definição dos determinantes dos comportamentos-alvo. A partir desses, foram propostas as intervenções de treinamento, capacitação, educação, reestruturação ambiental, persuasão, provisão de serviços, diretrizes e comunicação. Técnicas de mudança de comportamento (demonstração e automonitorização do comportamento, informações sobre consequências de saúde, entre outras) alicercearam o conteúdo da intervenção. Considerações finais e implicações para prática os modelos teóricos possibilitaram a estruturação de intervenção educativa com ênfase na proposição de estratégias para modificação de comportamentos, componente central no cuidado a pessoa com diabetes. Destaca-se a relevância de adoção de modelos comportamentais no planejamento da educação em saúde e o caráter complexo no delineamento da intervenção.

Resumen Objetivo presentar el Programa Diabetes em Dia (Dia-D): una intervención educativa para el automanejo de la diabetes tipo 2 enfocada en promover la alimentación saludable, la actividad física regular y el uso correcto de medicamentos, entre adultos con diabetes tipo 2. Método ensayo de propósito de intervención complejo basado en dos modelos conductuales: The ADCES7 Self-Care Behaviors™ (Association of Diabetes Care and Education Specialists); y Behavior Change Wheel (BCW). Resultados el marco conceptual de la BCW "Capacidad, Oportunidad, Motivación-Comportamiento (COM-B)" permitió definir los determinantes de las conductas objetivo. A partir de estos, se propusieron intervenciones de entrenamiento, empoderamiento, educación, reestructuración ambiental, persuasión, prestación de servicios, directrices y comunicación. Las técnicas de cambio de comportamiento (demostración y autocontrol del comportamiento, información sobre las consecuencias para la salud, entre otras) sustentaron el contenido de la intervención. Consideraciones finales e implicaciones para la práctica los modelos teóricos posibilitaron la estructuración de una intervención educativa con énfasis en la propuesta de estrategias para la modificación de la conducta, componente central en el cuidado de las personas con diabetes. Destaca la relevancia de adoptar modelos conductuales en la planificación de la educación para la salud y la complejidad del diseño de la intervención.

Abstract Objective to present the Diabetes em Dia (Dia-D) Program: an educational intervention for self-management in type 2 diabetes, focused on promoting healthy eating, being active, and taking medication, among adults with type 2 diabetes. Method a propositional essay of complex intervention based on two behavioral models: The ADCES7 Self-Care Behaviors™ (Association of Diabetes Care and Education Specialists); and the Behavior Change Wheel (BCW). Results BCW's conceptual framework "Capability, Opportunity, Motivation-Behaviour (COM-B)" made it possible to define the determinants of target behaviors. Based on these, interventions were proposed, such as training, enablement, education, environmental restructuring, persuasion, service provision, guidelines, and communication. Behavior change techniques (demonstration and self-monitoring of behavior, information on health consequences, among others) underpinned the intervention content. Final considerations and implications for practice the theoretical models enabled the structuring of an educational intervention with an emphasis on proposing strategies for behavior modification, a central component in caring for people with diabetes. The relevance of adopting behavioral models in health education planning and the complex nature of the intervention design stand out.

Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans / Disbiose intestinal, inflamação e diabetes tipo 2 em camundongos usando microbiota intestinal sintética de humanos diabéticos

The study was aimed to assess impact of high fat diet (HFD) and synthetic human gut microbiota (GM) combined with HFD and chow diet (CD) in inducing type-2 diabetes (T2D) using mice model. To our knowledge, this is the first study using selected human GM transplantation via culture based method coupled dietary modulation in mice for in vivo establishment of inflammation leading to T2D and gut dysbiosis. Twenty bacteria (T2D1-T2D20) from stool samples of confirmed T2D subjects were found to be morphologically different and subjected to purification on different media both aerobically and anerobically, which revealed seven bacteria more common among 20 isolates on the basis of biochemical characterization. On the basis of 16S rRNA gene sequencing, these seven isolates were identified as Bacteroides stercoris (MT152636), Lactobacillus acidophilus (MT152637), Lactobacillus salivarius (MT152638), Ruminococcus bromii (MT152639), Klebsiella aerogenes (MT152640), Bacteroides fragilis (MT152909), Clostridium botulinum (MT152910). The seven isolates were subsequently used as synthetic gut microbiome (GM) for their role in inducing T2D in mice. Inbred strains of albino mice were divided into four groups and were fed with CD, HFD, GM+HFD and GM+CD. Mice receiving HFD and GM+modified diet (CD/HFD) showed highly significant (P<0.05) increase in weight and blood glucose concentration as well as elevated level of inflammatory cytokines (TNF-α, IL-6, and MCP-1) compared to mice receiving CD only. The 16S rRNA gene sequencing of 11 fecal bacteria obtained from three randomly selected animals from each group revealed gut dysbiosis in animals receiving GM. Bacterial strains including Bacteroides gallinarum (MT152630), Ruminococcus bromii (MT152631), Lactobacillus acidophilus (MT152632), Parabacteroides gordonii (MT152633), Prevotella copri (MT152634) and Lactobacillus gasseri (MT152635) were isolated from mice [...].

O estudo teve como objetivo avaliar o impacto da dieta rica em gordura (HFD) e da microbiota intestinal humana sintética (GM) combinada com HFD e dieta alimentar (CD) na indução de diabetes tipo 2 (T2D) usando modelo de camundongos. Para nosso conhecimento, este é o primeiro estudo usando transplante de GM humano selecionado através do método baseado em cultura acoplada à modulação dietética em camundongos para o estabelecimento in vivo de inflamação que leva a T2D e disbiose intestinal. Vinte bactérias (T2D1-T2D20) de amostras de fezes de indivíduos T2D confirmados verificaram ser morfologicamente diferentes e foram submetidas à purificação em meios diferentes aerobicamente e anaerobicamente, o que revelou sete bactérias mais comuns entre 20 isolados com base na caracterização bioquímica. Com base no sequenciamento do gene 16S rRNA, esses sete isolados foram identificados como Bacteroides stercoris (MT152636), Lactobacillus acidophilus (MT152637), Lactobacillus salivarius (MT152638), Ruminococcus bromii (MT152639), Klebsiella aerogenides (MT152640), Bacteroides fragilis (MT152909), Clostridium botulinum (MT152910). Esses sete isolados foram, posteriormente, usados como microbioma intestinal sintético (GM) por seu papel na indução de T2D em camundongos. Linhagens consanguíneas de camundongos albinos foram divididas em quatro grupos e foram alimentadas com CD, HFD, GM + HFD e GM + CD. Camundongos que receberam a dieta modificada com HFD e GM + (CD / HFD) mostraram um aumento altamente significativo (P < 0,05) no peso e na concentração de glicose no sangue, bem como um nível elevado de citocinas inflamatórias (TNF-α, IL-6 e MCP-1) em comparação com os ratos que receberam apenas CD. O sequenciamento do gene 16S rRNA de 11 bactérias fecais obtidas de três animais selecionados aleatoriamente de cada grupo revelou disbiose intestinal em animais que receberam GM. Cepas bacterianas, incluindo Bacteroides gallinarum (MT152630), Ruminococcus [...].

Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans

Abstract The study was aimed to assess impact of high fat diet (HFD) and synthetic human gut microbiota (GM) combined with HFD and chow diet (CD) in inducing type-2 diabetes (T2D) using mice model. To our knowledge, this is the first study using selected human GM transplantation via culture based method coupled dietary modulation in mice for in vivo establishment of inflammation leading to T2D and gut dysbiosis. Twenty bacteria (T2D1-T2D20) from stool samples of confirmed T2D subjects were found to be morphologically different and subjected to purification on different media both aerobically and anerobically, which revealed seven bacteria more common among 20 isolates on the basis of biochemical characterization. On the basis of 16S rRNA gene sequencing, these seven isolates were identified as Bacteroides stercoris (MT152636), Lactobacillus acidophilus (MT152637), Lactobacillus salivarius (MT152638), Ruminococcus bromii (MT152639), Klebsiella aerogenes (MT152640), Bacteroides fragilis (MT152909), Clostridium botulinum (MT152910). The seven isolates were subsequently used as synthetic gut microbiome (GM) for their role in inducing T2D in mice. Inbred strains of albino mice were divided into four groups and were fed with CD, HFD, GM+HFD and GM+CD. Mice receiving HFD and GM+modified diet (CD/HFD) showed highly significant (P 0.05) increase in weight and blood glucose concentration as well as elevated level of inflammatory cytokines (TNF-, IL-6, and MCP-1) compared to mice receiving CD only. The 16S rRNA gene sequencing of 11 fecal bacteria obtained from three randomly selected animals from each group revealed gut dysbiosis in animals receiving GM. Bacterial strains including Bacteroides gallinarum (MT152630), Ruminococcus bromii (MT152631), Lactobacillus acidophilus (MT152632), Parabacteroides gordonii (MT152633), Prevotella copri (MT152634) and Lactobacillus gasseri (MT152635) were isolated from mice treated with GM+modified diet (HFD/CD) compared to strains Akkermansia muciniphila (MT152625), Bacteriodes sp. (MT152626), Bacteroides faecis (MT152627), Bacteroides vulgatus (MT152628), Lactobacillus plantarum (MT152629) which were isolated from mice receiving CD/HFD. In conclusion, these findings suggest that constitution of GM and diet plays significant role in inflammation leading to onset or/and possibly progression of T2D. .

Resumo O estudo teve como objetivo avaliar o impacto da dieta rica em gordura (HFD) e da microbiota intestinal humana sintética (GM) combinada com HFD e dieta alimentar (CD) na indução de diabetes tipo 2 (T2D) usando modelo de camundongos. Para nosso conhecimento, este é o primeiro estudo usando transplante de GM humano selecionado através do método baseado em cultura acoplada à modulação dietética em camundongos para o estabelecimento in vivo de inflamação que leva a T2D e disbiose intestinal. Vinte bactérias (T2D1-T2D20) de amostras de fezes de indivíduos T2D confirmados verificaram ser morfologicamente diferentes e foram submetidas à purificação em meios diferentes aerobicamente e anaerobicamente, o que revelou sete bactérias mais comuns entre 20 isolados com base na caracterização bioquímica. Com base no sequenciamento do gene 16S rRNA, esses sete isolados foram identificados como Bacteroides stercoris (MT152636), Lactobacillus acidophilus (MT152637), Lactobacillus salivarius (MT152638), Ruminococcus bromii (MT152639), Klebsiella aerogenides (MT152640), Bacteroides fragilis (MT152909), Clostridium botulinum (MT152910). Esses sete isolados foram, posteriormente, usados como microbioma intestinal sintético (GM) por seu papel na indução de T2D em camundongos. Linhagens consanguíneas de camundongos albinos foram divididas em quatro grupos e foram alimentadas com CD, HFD, GM + HFD e GM + CD. Camundongos que receberam a dieta modificada com HFD e GM + (CD / HFD) mostraram um aumento altamente significativo (P 0,05) no peso e na concentração de glicose no sangue, bem como um nível elevado de citocinas inflamatórias (TNF-, IL-6 e MCP-1) em comparação com os ratos que receberam apenas CD. O sequenciamento do gene 16S rRNA de 11 bactérias fecais obtidas de três animais selecionados aleatoriamente de cada grupo revelou disbiose intestinal em animais que receberam GM. Cepas bacterianas, incluindo Bacteroides gallinarum (MT152630), Ruminococcus bromii (MT152631), Lactobacillus acidophilus (MT152632), Parabacteroides gordonii (MT152633), Prevotella copri (MT152634) e Lactobacillus Gasseri (MT152635D), foram tratadas com dieta modificada / CD) em comparação com as linhagens Akkermansia muciniphila (MT152625), Bacteriodes sp. (MT152626), Bacteroides faecis (MT152627), Bacteroides vulgatus (MT152628), Lactobacillus plantarum (MT152629), que foram isoladas de camundongos recebendo CD / HFD. Em conclusão, esses resultados sugerem que a constituição de GM e dieta desempenham papel significativo na inflamação levando ao início ou/e possivelmente à progressão de T2D.

Grado de oxidación en pacientes con Diabetes Mellitus Tipo 2 / Oxidation degree in patients with Type 2 Diabetes Mellitus

La peroxidación lipídica es un proceso complejo que hace referencia a la degradación oxidativa de los lípidos, a través del cual los radicales libres capturan electrones de los lípidos en las membranas celulares, lo cual compromete la integridad y la función de la membrana. Mediante una serie de reacciones en cadena, se forman los peróxidos lipídicos que se degradan para formar compuestos reactivos como el malondialdehído (MDA) y 4-hidroxinonenal, los cuáles pueden ser cuantificados por diferentes metodologías. Objetivo: El presente trabajo se realizó con la finalidad establecer el grado de oxidación en una población con diabetes tipo 2 (DM2).Métodos: Estudio descriptivo, analítico y transversal; muestra de 55 personas, conformada por 30 controles entre 25-35 años y 25 pacientes con DM2 entre 25-50 años, se les determinó glicemia, triglicéridos, colesterol total, HDL-Colesterol y LDL-Colesterol por método colorimétrico enzimático, así como se determinó la concentración de 4-hidroxinonenal como un marcador de estrés oxidativo Resultados: Los valores de 4-hidroxinonenal en la población control oscilaron entre 2,61y 6,83 µmol/L y en los diabéticos de 28,99 y 73,74 µmol/L., encontrándose diferencias estadísticamente significativas entre ambas poblaciones, así como en el perfil lipídico y en la glicemia entre ambos grupos. Conclusión: Los resultados demuestran una elevación de la peroxidación lipídica en pacientes diabéticos, lo cual es indicativo de estrés oxidativo y riesgo adicional en estos pacientes que podrían conllevar a las complicaciones crónicas dela diabetes tipo 2(AU)

Lipid peroxidation is a complexprocess that refers to the oxidative degradation of lipids, through which free radicals capture electrons from lipids incell membranes, which compromises the integrity and functionof the membrane. Trough a series of chain reactions, lipidperoxides are formed that degrade to form reactive compoundssuch as malondialdehyde (MDA) and 4-hydroxynonenal, whichcan be quantified by different methodologies. Objective: The present work was carried out with the purpose ofestablishing the degree of oxidation in a population withtype 2 diabetes (DM2). Methods: the sample was 55 people,made up of 30 controls between 25-35 years and 25 patientswith DM2 and between 25-50 years, glycemia, triglycerides,total cholesterol, HDL-Cholesterol and LDL-Cholesterol were etermined by colorimetric method. enzymatic, as well as theconcentration of 4-hydroxynonenal was determined as a markerof oxidative stress. Results: The values of 4-hydroxynonenal inthe control population ranged between 2.61 and 6.83 µmol/Land in diabetics 28.99 and 73.74 µmol/L., finding statisticallysignificant differences between both populations, as well as inthe lipid profile and glycemia between both groups. Conclusion:The results show an elevation of lipid peroxidation in diabeticpatients, which is indicative of oxidative stress and additionalrisk in these patients that could lead to chronic complications oftype 2 diabetes(AU)

Costo-efectividad del tratamiento con insulina para el control de diabetes mellitus tipo 2 en México / Cost-effectiveness in insulin treatment for type 2 diabetes mellitus control in Mexico

Resumen Objetivo: Identificar la intervención más costo-efectiva para el tratamiento de la diabetes mellitus tipo 2, en el primer nivel de atención, cuando el paciente requiere del uso de algún tipo de insulina, con base en estudios clínicos previos. Material y métodos: Se efectuó un análisis costo-efectividad desde la perspectiva del proveedor. Se obtuvieron los costos de tres tipos de insulina como fármaco de control: insulina glargina, insulina protamina neutra de Hagedorn (NPH) e insulina lispro/lispro protamina 25-75 UI. Los indicadores de efectividad se obtuvieron de estudios previos que analizaron el efecto de los fármacos sobre la hemoglobina glucosilada (HbA1c). Resultados: La intervención que presentó el mejor coeficiente costo- efectividad fue el tratamiento con insulina glargina, con un valor de 570, comparado con 643.1 de la insulina NPH y 572.6 de la insulina lispro/lispro protamina 25-75 UI. Conclusiones: La insulina glargina es el tratamiento en pacientes que requieren insulinas y no presentan daño microvascular, la que presenta la mejor evidencia para invertir debido a su costo y su efectividad (analizados a través del coeficiente costo-efectividad). Estos resultados pueden considerarse en el contexto mexicano para mejorar la adquisición de medicamentos y los estándares de tratamiento para pacientes con diabetes mellitus tipo 2.

Abstract Objective: To identify the best cost-effective intervention for the treatment of type 2 diabetes mellitus, at the first level of care, when the patient requires the use of insulin, based on previous clinical analysis. Materials and methods: A cost-effectiveness analysis was carried out, from the provider perspective. The cost of three types of insulin as a control drug were obtained: glargine insulin, neutral protamine Hagedorn (NPH) insulin and lispro insulin/lispro protamine 25-75 IU. The effectiveness indicators were obtained from previous studies that analyzed the effect on glycated hemoglobin (HbA1c). Results: The intervention that presented the best cost-effective coefficient was the treatment with glargine insulin, with a value of 570, compared to 643.1 for the NPH insulin and 57 for the lispro/lispro protamine insulin. Conclusions: Glargine insulin is the treatment in patients who require insulins, without microvascular damage, that presents the best evidence to invest in, because of its cost and efficiency (analyzed through a cost- efficiency coefficient). These results may be considered in the Mexican context to improve drug's acquisition and the treatment standards to treat type 2 diabetes mellitus.

Diabetes tipo 2 ¿En la vida real es posible lograr la meta glucémica? / Type 2 Diabetes. Is it possible to achieve the glycemic goal in real life?

Resumen Lograr control glucémico en diabetes tipo 2 (DMT2) previene, o enlentece las complicaciones crónicas y prolonga la supervivencia. Objetivo: analizar metas de control metabólico en adultos con DMT2 tratados por especialistas en Argentina y su relación con la adherencia a la medicación prescrita, las diferentes estrategias de tratamiento, la antigüedad de la enfermedad, las variables de calidad de vida y pre sencia de complicaciones crónicas de DMT2. Métodos: diseño transversal; estudio multicéntrico realizado en 28 centros de Argentina durante 2018. La muestra se seleccionó en forma aleatoria y sistemática. Se aplicó cuestionario de adherencia Morisky-Green-Levine y OMS-5 para calidad de vida. Se analizaron antecedentes de enfermedad y marcadores de laboratorio. Resultados: de 1329 casos de DMT2 incluidos, el 60.2% logró la meta. Respecto al tratamiento farmacológico en diabetes: el 5.1% estaba sin medicación, 47.5% con 1 fármaco, el 34.5% con 2, el 12.9% con 3 o más; a su vez, con insulina (sola o combinada) el 38.1%. Según cuestionario, adhería al tratamiento el 68.4% y el 72.6% alcanzó A1C < 7%. Entre los no adherentes, alcan zó la meta glucémica el 27.4%. Lograr esta meta se asoció con edad mayor de 65 años (p < 0.0001), mayor score de adherencia (p < 0.0001), tener medicina prepaga (p < 0.0001), y realizar actividad física (p < 0.02). El peor control metabólico se asoció con antigüedad de DMT2 (p < 0.0001), insulinoterapia (p < 0.0001) y síntomas de depresión (p < 0.002) Conclusiones: Los más jóvenes y los más vulnerables presentaron menor adherencia; en ellos intervenir e intensificar tratamiento más tempranamente permitiría mejores resultados.

Abstract Introduction: Achieving glycemic control in type 2 diabetes(T2D) prevents or delays chronic complications and extends survival. Aim: to analyze metabolic control goals in adults with T2DM, treated by specialists in their usual practice in Argentina, and their relationship with adherence to prescribed medications, different treatment strategies, time of diagnosis, quality of life variables and presence of chronic complications of T2DM. Methods: cross-sectional design; multicenter study conducted in 28 centers in Argentina during 2018. The sample was selected randomly and systematically. Morisky-Green-Levine and WHO-5 adherence questionnaire for quality of life was applied. History of disease and laboratory markers were analyzed. Results: of 1329 DMT2 cases included, 60.2% achieved the goal. Regarding pharmacological treatment in diabetes: 5.1% were without medication, 47.5% with 1 drug, 34.5% with 2, 12.9% with 3 or more; in turn, with insulin (alone or combined) 38.1%. According to the questionnaire, 68.4% adhered to treatment and 72.6% reached A1C <7%. Among the non-adherents, 27.4% reached the goal. Achieving the glycemic goal was associated with age ≥ 65 years (p < 0.0001), higher adherence score (p < 0.0001), private health insurance (p < 0.0001), and physical activity (p < 0.02). The worst metabolic control was associated with time of DMT2 diagnosis (p<0.0001), insulin therapy (p < 0.0001) and symptoms of depression (p < 0.002) Conclusions: The youngest and most vulnerable presented lower values for adherence; intervening and intensifying the treatment earlier in them would allow better results.

Intervención educativa sobre la diabetes tipos 2 en una población sin hogar de Miami-Dade / Educational Intervention on Type 2 Diabetes in a Miami-Dade Homeless Population

Resumen: Objetivo: Las personas sin hogar tienen significativamente más necesidades de salud y tasas más altas de morbilidad y mortalidad, así como más hospitalizaciones y/o rehospitalizaciones que la población en general, causadas por factores como la pobreza extrema, el acceso deficiente a la atención médica y los desafíos en la adherencia a los medicamentos, por lo cual el presente estudio se propuso aplicar una intervención educativa sobre la diabetes tipo 2, dirigida a las personas sin hogar residentes en un refugio, con el fin de mejorar las técnicas de autocontrol y autocuidado de esta enfermedad crónica. Materiales y métodos: La intervención educativa fue realizada en un refugio para personas sin hogar de Miami Dade, con 250 participantes y consistió en tres sesiones de autocontrol y autocuidado de la diabetes y una lista de recursos de la comunidad en el idioma de preferencia de la persona (inglés o español). Las evaluaciones incluyeron una encuesta antes y después de la intervención y una evaluación previa y posterior mediante el cuestionario Diabetes Knowledge (DKQ-24). Resultados: Datos demográficos: 88% hombres y 12% mujeres, 40% hispanos, 36% afroamericanos, 26% caucásicos, idioma 64% inglés y 36% español. Hubo una diferencia significativa en la medición antes y después de dos meses de la intervención educativa (p <0,000). Conclusiones: La intervención educativa para mejorar la calidad de vida, el autocontrol y el autocuidado de los pacientes sin hogar con diabetes tipo 2 tuvo un efecto positivo y estos resultados pueden proporcionar la base para intervenciones futuras que ayuden a los profesionales de la salud a identificar las necesidades y abordarlas a través de intervenciones educativas adaptadas al contexto. Aprobación n. IRB 17-OR-372-ME del Institutional Review Board (IRB).

Abstract: Objective: Homeless people have significantly more health needs and higher rates of morbidity and mortality, as well as more hospitalizations and / or rehospitalizations than the general population, caused by factors such as extreme poverty, poor access to medical care and the challenges in adherence to medications, for which the present study set out to apply an educational intervention on type 2 diabetes, aimed at homeless people living in a shelter, in order to improve self-control and self-care techniques of this chronic disease. Materials and methods: The educational intervention was conducted in a Miami Dade homeless shelter with 250 participants and consisted of three diabetes self- management and self-care sessions and a list of community resources in the preferred language of the community. person (English or Spanish). The evaluations included a survey before and after the intervention and a pre- and post-evaluation using the Diabetes Knowledge questionnaire (DKQ-24). Results: Demographic data: 88% male and 12% female, 40% Hispanic, 36% African American, 26% Caucasian, 64% English and 36% Spanish language. There was a significant difference in the measurement before and after two months of the educational intervention (p <0.001). Conclusions: Educational intervention to improve the quality of life, self-control, and self-care of homeless patients with type 2 diabetes had a positive effect and these results may provide the basis for future interventions that help health professionals to identify needs and address them through context-specific educational interventions. Approval n. IRB 17-OR-372-ME of the Institutional Review Board (IRB).

Características sociodemográficas asociadas a la adherencia del tratamiento en adultos con Diabetes Tipo 2 / Sociodemographical characteristics associated with adherence to treatment in adults with type 2 Diabetes

Resumen: Objetivo: Establecer la asociación de las características sociodemográficas y la adherencia al tratamiento en personas adultas mexicanas con Diabetes Tipo 2. Materiales y Método: Diseño descriptivo transversal, la población estuvo constituida por adultos mayores de 18 de edad con diagnóstico de DT2, que acudieron a una clínica de diabetes de un hospital público. La muestra estuvo constituida por 100 participantes, se incluyeron adultos conscientes, con diagnóstico de DT2, con evolución mínima de tres años con la enfermedad. Para medir la adherencia al tratamiento se utilizó el Test de Adherencia al Tratamiento de Morisky, Green y Levine. Resultados: Predominó el sexo femenino (62%), los participantes entre 50 a 59 años fueron los que más participaron (59%); cerca de la mitad de los participantes había concluido la primaria (46%), y la mayoría de ellos reportaron tener pareja (69%). El 23% de los participantes reportaron tener 3 años con DT2, solo el 38% de los encuestados realizan ejercicio físico de 10 a 15 minutos al día y el 28% no realizaba ejercicio físico; la mayoría se encontraba con un tratamiento farmacológico basado en hipoglucemiantes orales (82%). La edad se asoció con la adherencia al tratamiento (p<0.005). Conclusiones: La edad fue la única característica sociodemográfica que se asoció significativamente con la adherencia al tratamiento en personas adultas mexicanas con Diabetes Tipo 2. El personal de salud, principalmente los que se encuentran en el primer nivel de atención, deben de enfocarse a promover la adherencia al tratamiento en pacientes que padecen DT2, teniendo en cuenta sus características sociodemográficas, particularmente la edad.

Abstract: Objective: To establish the association of sociodemographic characteristics and treatment adherence in Mexican adults with Type 2 Diabetes. Materials and Methods: A descriptive, cross-sectional study was made in Mexican adults over 18 years with Type 2 Diabetes who attended a diabetes clinic of a public hospital. The sample were 100 adults. Conscious adults, diagnosed with DT2, with a minimum evolution of three years with the diagnostic were included. The Morisky, Green and Levine´s test was used to identify the adherence to the treatment. Results: The female sex predominated (62%), the adults between 50-59 years were the most representative group (59%); el 46% had primary school and 69% were married. The 23% of the sample has 3 years with the diagnostic, only 38% of the respondents do exercise 10-15 minutes a day and 28% did not do exercise; the majority report having a pharmacological treatment based on oral hypoglycemic agents (82%). The age was associate with the adherence to the treatment (p<.005). Conclusions: Age was the only sociodemographic characteristic that was significantly associated with adherence to treatment in Mexican adults with Type 2 Diabetes. Health personnel, mainly those at the first level of care, should focus on promoting adherence to treatment in patients suffering from DT2, taking into account their sociodemographic characteristics, especially age.

Factores de riesgo para desarrollar diabetes tipo 2 en homosexuales: Una revisión sistemática de literatura / Risk factors for developing type 2 diabetes in homosexuals: A systematic literature review

Resumen: Objetivo: Identificar la literatura científica disponible, sobre factores de riesgo para desarrollar diabetes tipo 2 en homosexuales. Material y Métodos: Se realizaron búsquedas de artículos científicos publicados entre el año 2014 y 2020 en idioma inglés y español, en 5 bases de datos electrónicas: Biblioteca Virtual en Salud, Google Académico, Red de Revistas Científicas de América Latina y el Caribe, España y Portugal, Scientific Electronic Library Online y Biblioteca Nacional de Medicina de los Estados Unidos. Se hicieron combinaciones con los descriptores y operadores lógicos booleanos AND y OR: Obesidad OR Diabetes AND Risk AND Homosexual, Diabetes AND Homosexual, Obesity AND Homosexual, Obesity AND Diabetes AND Homosexual, Risk AND Diabetes AND Obesidad AND Homosexual de acuerdo al Medical Subject Headings. Para seleccionar los estudios se siguió la guía de Joanna Briggs Institute Critical Appraisal tools en español para estudios de prevalencia analíticos. Resultados: De 98 estudios, se incluyeron 8 estudios de origen de Estados Unidos y publicados en inglés. La muestra de los estudios oscilo entre 219 y 136,878 participantes con edad entre 18 y 65 años. La evidencia disponible sugiere que los principales factores de riesgo para el desarrollo de diabetes tipo 2 en homosexuales son: obesidad, depresión, estrés, falta de atención a la salud, la inactividad física, consumo de tabaco y alcohol, tener pre diabetes, hipertensión arterial, altos niveles de colesterol y antecedentes familiares con diabetes tipo 2. Conclusiones: En conclusión, algunos de estos factores de riesgos no son considerados por las organizaciones de diabetes, mostrando diferencias en la población heterosexual.

Abstract: Objective: To identify the available scientific literature on risk factors for developing type 2 diabetes in homosexuals. Material and Methods: Scientific articles published between 2014 and 2020 in English and Spanish were searched in 5 electronic databases: Virtual Health Library, Google Scholar, Network of Scientific Journals from Latin America and the Caribbean, Spain and Portugal, Scientific Electronic Library Online and National Library of Medicine of the United States. Combinations were made with the Boolean logical descriptors and operators AND and OR: Obesity OR Diabetes AND Risk AND Homosexual, Diabetes AND Homosexual, Obesity AND Homosexual, Obesity AND Diabetes AND Homosexual, Risk AND Diabetes AND Obesity AND Homosexual according to Medical Subject Headings. To select the studies, the Joanna Briggs Institute Critical Appraisal tools guide in Spanish for analytical prevalence studies was followed. Results: Of 98 studies, 8 studies of United States origin and published in English were included. The sample of the studies ranged between 219 and 136 878 participants aged between 18 and 65 years. The available evidence suggests that the main risk factors for the development of type 2 diabetes in homosexuals are obesity, depression, stress, lack of health care, physical inactivity, tobacco and alcohol consumption, having prediabetes, high blood pressure, high Cholesterol levels and family history with type 2 diabetes. Conclusions: In conclusion, some of these risk factors are not considered by diabetes organizations, showing differences in the heterosexual population.

Estudio comparativo de la terapia de metformina sola y metformina combinada con terapia de tintura de notholaena nivea en pacientes con diabetes tipo 2 / Comparative study of metformin therapy alone and metformin combined with notholaena nivea tincture therapy in patients with type 2 diabetes

La diabetes tipo 2 es un trastorno metabólico progresivo complejo, que representa una amenaza significativa para la salud humana y representa más del 91% de todos los casos de diabetes. Objetivo: evaluar el efecto de la adición de tintura de Notholaena nivea al tratamiento con metformina en pacientes con tolerancia alterada a la glucosa (IGT) y diabetes de tipo 2 (DMT2). Materiales y Método: Ensayo clínico unicentral, aleatorizado, simple ciego, controlado con placebo. Todos los participantes con diagnóstico de IGT y DMT2 que tomaban metformina fueron asignados aleatoriamente a recibir kits con tintura de Notholaena nivea autentica (40 pacientes) o placebo (58 pacientes), fijando 6 gotas diarias, 30 minutos antes del desayuno y almuerzo durante 26 semanas, se hicieron 3 controles (0, 13 y 26 semanas) midiendo glucosa plasmática en ayunas (FPG), nivel de hemoglobina glucosilada (HbA1C) y perfil lipídico. Resultados: del grupo de tratamiento (tintura de Notholaena nivea más metformina) fueron significativamente eficientes a las 13 semanas de iniciado el ensayo, manteniendo la directriz de reducción de glucosa plasmática (FPG), al iniciar el estudio el grupo control y tratamiento obtuvieron niveles de FPG similares con valores de .57±1.7 y 7.84±1.9 mmol/l respectivamente (p>0.05), a las 13 semanas se redujo a 7.21±1.mmol/l para el grupo control y 6.49±2.33 mmol/l para el grupo tratamiento (p<0.01), mientras que a la semana 26 el grupo control reporto 7.09±1.41 mmol/l en tanto el grupo tratamiento obtuvo 5.98±0.71 mmol/l (p<0.01). Hubo reducción de los niveles de HbA1C dentro de los grupos, pero no se evidenciaron diferencias por efecto del tratamiento. En el perfil lipídico el tratamiento de Metformina sola evidencio una mejor respuesta con la reducción de colesterol total y aumento de lipoproteínas de alta densidad (HDL) pero aumento la concentración de triglicéridos, mientras que el tratamiento con tintura de Notholaena nivea mantuvo los perfiles lipídicos al igual que en un inicio (p>0.05). Conclusiones: el tratamiento combinado de metformina más tintura de Notholaena nivea reduce acelerada y eficazmente las concentraciones de FPG en sangre de pacientes con IGT o DMT2, pero es ineficaz en el tratamiento del perfil lipídico(AU)

Type 2 diabetes is a complex progressive metabolic disorder, which represents a significant threat to human health and accounts for more than 91% of all diabetes cases. Objective: to evaluate the effect of adding Notholaena nivea tincture to metformin treatment in patients with impaired glucose tolerance (IGT) and type 2 diabetes (DMT2). Materials and Method: Unicentral, randomized, single-blind, placebo-controlled clinical trial. All participants diagnosed with IGT and T2DM who were taking metformin were randomly assigned to receive authentic Notholaena nivea tincture kits (40 patients) or placebo (58 patients), setting 6 drops daily, 30 minutes before breakfast and lunch for 26 weeks. , 3 controls were made (0, 13 and 26 weeks) measuring fasting plasma glucose (FPG), glycosylated hemoglobin level (HbA1C) and lipid profile. Results: the treatment group (Notholaena nivea tincture plus metformin) were significantly efficient at 13 weeks from the start of the trial, maintaining the plasma glucose reduction guideline (FPG), at the start of the study the control and treatment groups obtained levels of Similar FPG with values of .57±1.7 and 7.84±1.9 mmol/l respectively (p>0.05), at 13 weeks it was reduced to 7.21±1.mmol/l for the control group and 6.49±2.33 mmol/l for the treatment group (p<0.01), while at week 26 the control group reported 7.09±1.41 mmol/l while the treatment group obtained 5.98±0.71 mmol/l (p<0.01). There was a reduction in HbA1C levels within the groups, but no differences due to treatment effect were observed. In the lipid profile, the treatment with Metformin alone showed a better response with the reduction of total cholesterol and an increase in high-density lipoproteins (HDL) but increased the concentration of triglycerides, while the treatment with Notholaena nivea tincture maintained the lipid profiles at the same as at the beginning (p>0.05). Conclusions: the combined treatment of metformin plus Notholaena nivea tincture rapidly and effectively reduces FPG concentrations in the blood of patients with IGT or DMT2, but it is ineffective in the treatment of the lipid profile.Keywords: Type 2 diabetes, Notholaena nivea, FPG, Metformin, lipid(AU)

Maxilectomia em paciente diabética tipo II, diagnosticada com Mucormicose rinomaxilar, com posterior reabilitação protética: relato de caso / Maxillectomy in a type II diabetic patient, diagnosed with rhinomaxillary mucormycosis, with subsequent prosthetic rehabilitation: case report / Maxilectomía en paciente diabética tipo II diagnosticada de mucormicosis rinomaxilar, con posterior rehabilitación protésica: reporte de caso

A mucormicose é uma infecção fúngica angioinvasiva que afeta uma ampla faixa etária, geralmente imunodeprimidos, sem predileção por gênero ou raça e com alta taxa de mortalidade. Essa infecção inicia se no nariz, devido à inalação dos esporos, podendo-se espalhar pelos seios paranasais, órbita e estruturas intracranianas. As características clínicas incluem parestesia perinasal, celulite periorbitária, rinorréia, obstrução nasal, epistaxe e diminuição de peso. O tratamento efetivo dessa comorbidade compoe uma combinação de manejo clínico e medicamentoso, conjuntamente com desbridamento cirúrgico radical do tecido infectado e/ou necrótico. O caso clínico descrito nesse trabalho refere-se a uma paciente diagnosticada com Mucormicose rino maxilar e diabetes do tipo II, a qual foi submetida a procedimento cirúrgico de hemimaxilectomia do lado esquerdo com posterior reabilitação protética para selamento de comunicação buco-naso-sino-etmoidal... (AU)

Mucormycosis is an angioinvasive fungal infection that affects a wide age group, usually immunocompromised, with no gender or race predilection, and with a high mortality rate. This infection starts in the nose, due to the inhalation of spores, and can spread through the paranasal sinuses, orbit and intracranial structures. Clinical features include perinasal paresthesia, periorbital cellulitis, rhinorrhea, nasal obstruction, epistaxis and weight loss. Effective treatment of this comorbidity comprises a combination of clinical and drug management, together with radical surgical debridement of infected and/or necrotic tissue. The clinical case described in this work refers to a patient diagnosed with Mucormycosis Rhinomaxilla and Type II diabetes, who underwent a surgical procedure of left hemimaxillectomy with subsequent prosthetic rehabilitation for sealing of the bucco nasal-sino-ethmoidal communication... (AU)

La mucormicosis es una micosis angioinvasiva que afecta a un amplio grupo de edad, habitualmente inmunodeprimidos, sin predilección de género ni raza, y con una alta tasa de mortalidad. Esta infección comienza en la nariz, debido a la inhalación de esporas, y puede extenderse a través de los senos paranasales, la órbita y las estructuras intracraneales. Las características clínicas incluyen parestesia perinasal, celulitis periorbitaria, rinorrea, obstrucción nasal, epistaxis y pérdida de peso. El tratamiento eficaz de esta comorbilidad comprende una combinación de manejo clínico y farmacológico, junto con un desbridamiento quirúrgico radical del tejido infectado y / o necrótico. El caso clínico descrito en este trabajo se refiere a una paciente diagnosticada de Mucormicosis Rinomaxilar y diabetes Tipo II, que fue sometida a un procedimiento quirúrgico de hemimaxilectomía izquierda con posterior rehabilitación protésica para sellar la comunicación buco-nasal-sino-etmoidal... (AU)

Retinopatia diabética, qualidade de vida e capacidade de resiliência: associação complexa / Diabetic retinopathy, qualify of life, and resilience: a complex association

Introdução: Avaliar o quanto a Retinopatia Diabética (RD) pode interferir na qualidade de vida (QV) e alterar a capacidade de resiliência de pacientes diabéticos tipo 2 que realizam acompanhamento em clínica de referência em cidade no sul do Brasil. Métodos: Participaram 220 pacientes que realizaram o exame padrão ouro para RD (angiorretinografia fluoresceínica-AGF), avaliados entre junho/2015-outubro/2017. Instrumentos utilizados: Whoqol-Breff, Resilience Scale de Wagnild&Young, questionário autoaplicado (dados sociodemográficos, de saúde física e mental) e exames laboratoriais. Resultados: Prevalência de RD 73,3%( 18,76% leve e 81,24% moderada/grave). Pacientes com RD leve apresentaram níveis de glicemia de jejum em média 49,97 (p<0,01,IC 83,27;-16,67) mais elevados que aqueles sem RD e, em média, 20,50 (p=0,01,IC 50,60;-9,58) acima dos com RD moderada/grave. A capacidade de resiliência dos pacientes com RD moderada/grave foi em média 9,32 (p=0,01,IC2,05;16,59) acima daqueles com RD leve. Quanto à QV: domínio psicológico - pacientes com RD moderada/grave obtiveram médias 6,79 (p=0,02,IC-0,72;12,85) acima daqueles com RD leve; domínio social e Whoqol total esse mesmo grupo apresentou médias 9,27 (p=0,04,IC0,21;18,33) e 6,33 (p=0,02,IC1,05;11,60) vezes maiores quando comparados aos - com RD leve. A análise multivariada apresentou RP de 1,030 (IC 1.010 - 1.06) de piora da QV, quando ajustada para idade e glicemia de jejum, em relação aos pacientes com RD leve, quando comparados aos pacientes sem ou com RD moderada/grave. Conclusão: Pacientes com RD leve apresentaram piores níveis glicêmicos, pior capacidade de resiliência e QV quando comparados a pacientes com RD moderada/grave. A hiperglicemia crônica e a dificuldade de lidar com as limitações e mudanças que a RD impõe podem influenciar negativamente na evolução das complicações destes pacientes.

Introduction: To assess to which extent diabetic retinopathy (DR) can interfere with quality of life (QoL) and alter the resilience of patients with type 2 diabetes mellitus followed up by a referral clinic in a city in the South region of Brazil. Methods: Participants of this study were 220 patients who underwent the gold standard test for DR (fluorescein angiography [FA]) and were seen between June 2015 and October 2017. We used the WHOQoLBref and Wagnild & Young's Resilience Scale instruments, as well as a self-administered questionnaire (sociodemographic data, physical and mental health data) and laboratory examinations. Results: There was a prevalence of DR of 73.3% (18.76% of mild cases and 81.24% of moderate/severe cases). Patients with mild DR presented fasting glycemia levels that were on average 49.97 (p<0.01, CI-83.27;-16.67) higher than those without DR, and on average 20.50 (p=0.01, CI-50.60;-9.58) higher than those with moderate/severe DR. The resilience of patients with moderate/severe DR was on average 9.32 (p=0.01, CI2.05;16.59) higher than that of those with mild DR. As to their QoL, in the psychological domain, patients with moderate/severe DR obtained mean scores that were 6.79 (p=0.02,CI-0.72;12.85) higher than those with mild DR; as to the social domain and total WHOQoL scores, the same group presented mean scores 9.27 (p=0.04,CI0.21;18.33) and 6.33 (p=0.02,CI1.05;11.60) times higher when compared to those with mild DR. A multivariate analysis presented a prevalence ratio of 1.030 (CI1.010-1.06) of worsening QoL when adjusted for age and fasting glycemia considering patients with mild DR in comparison to those without DR or with moderate/severe DR. Conclusion: Patients with mild DR presented worse glycemic levels, as well as inferior resilience and QoL when compared to patients with moderate/severe DR. Chronic hyperglycemia and difficulties in coping with limitations and lifestyle changes imposed by DR can negatively influence the progression of complications in these patients.

La evidencia científica de las consecuencias de la modernidad / Scientific evidence of the consequences of modernity

Resumen La prevalencia de diabetes tipo 2 (DT2) en México es del 14.4%. La enfermedad se caracteriza por un estado de hiperglucemia e inflamación crónica secundaria a la resistencia y la secreción inadecuada de insulina. Dentro de sus factores de riesgo destacan la obesidad, el sedentarismo, las dietas hipercalóricas y las variantes genéticas. Durante décadas, diferentes grupos de investigación básica y aplicada han trabajado de forma interdisciplinaria para ofrecer evidencia científica que ha ayudado a entender los mecanismos implicados en la fisiopatología de la DT2 en pacientes mexicanos. Sin embargo, hoy en día la urgencia de conseguir mejores propuestas de prevención y manejo del paciente con DT2 hace necesario el uso de la medicina traslacional, que integra el conocimiento científico con el uso de tecnologías innovadoras para brindar una atención integral. El presente documento describe de forma concisa y con un enfoque traslacional las implicaciones de la interacción de factores de riesgo ambientales y genéticos en el desarrollo de obesidad infantil y DT2 en México.

Abstract The prevalence of type 2 diabetes (T2D) in Mexico is 14.4%. This disease is characterized by a state of hyperglycemia and chronic inflammation secondary to inadequate insulin secretion and its resistance. Among its risk factors for metabolic diseases development, the interaction between obesity, sedentary lifestyle, hypercaloric diets and genetic variants play an important role. For decades, different basic and applied research groups have worked in an interdisciplinary way to provide scientific evidence that has helped to understand the mechanisms involved in the pathophysiology of T2D in Mexicans. However, today the urgency of the advance and better proposals for prevention and management of patients with T2D makes it necessary to use translational medicine, which integrates scientific knowledge with the use of innovative technologies to provide comprehensive health care. In this sense, the present document concisely describes, with a translational approach, the implications of the interaction of environmental and genetic risk factors in the development of childhood obesity and T2D in Mexico.